About Instituto de Diabetes, Obesidad y Nutricion
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Instituto de Diabetes, Obesidad y Nutricion
During the past decade, Instituto de Diabetes, Obesidad y Nutricion conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
2013-10-29
2017-07-10
Completed
2,139
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
2022-10-11
2027-10-07
Recruiting
15,000
A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)
2022-11-30
2024-07-04
Recruiting
250
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Instituto de Diabetes, Obesidad y Nutricion
According to Clinical.Site data, the most researched conditions in "Instituto de Diabetes, Obesidad y Nutricion" are
"Cardiovascular Disease" (2 trials), "Hyperlipidemia" (1 trials), "Obesity" (1 trials), "Overweight" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Instituto de Diabetes, Obesidad y Nutricion" in a lesser frequency.
Clinical Trials Intervention Types at Instituto de Diabetes, Obesidad y Nutricion
Most popular intervention types in "Instituto de Diabetes, Obesidad y Nutricion" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Tirzepatide" (3 trials), "Dulaglutide" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Bococizumab (PF-04950615; RN316)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto de Diabetes, Obesidad y Nutricion
The vast majority of trials in "Instituto de Diabetes, Obesidad y Nutricion" are
6 trials for "All" genders.
Clinical Trials Status at Instituto de Diabetes, Obesidad y Nutricion
Currently, there are NaN active trials in "Instituto de Diabetes, Obesidad y Nutricion".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Instituto de Diabetes, Obesidad y Nutricion,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Diabetes, Obesidad y Nutricion, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".